Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroScan is a leading provider of microbiology solutions, specializing in automated systems for bacterial identification and antimicrobial susceptibility testing (AST). Originally an independent entity and later part of Dade Behring, the MicroScan product line is now a core component of Siemens Healthineers' diagnostic portfolio. The systems, such as the WalkAway plus and autoSCAN-4, are used in clinical laboratories worldwide to identify pathogens and determine the most effective antibiotic treatments. Their technology focuses on accuracy, reliability, and streamlining laboratory workflows to improve patient outcomes in infectious disease management. MicroScan's extensive menu of panels allows for the detection of emerging resistance, making it a critical tool in the global effort to manage antimicrobial stewardship. The brand continues to be a market leader in the microbiology diagnostic space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DADE MicroScan.